← Evidence map

ArticlePharmacology research & perspectives2020

Structurally unique PARP-1 inhibitors for the treatment of prostate cancer.

Ali Divan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32342655